GL1X · GenesisL1 explorer

MolNFT v1 · #151842 · protein

Crystal structure of human dermatan sulfate epimerase 1

6HZN · Dermatan-sulfate epimerase: “Crystal structure of human dermatan sulfate epimerase 1”. X-ray diffraction, 4 ligands (NAG, MAN, BMA), 10 pockets (best druggability 0.55). MolNFT v1 #151842 on GenesisL1: 3D structure, binding sites…

PDB
6HZN
Type
protein
Length
743 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dermatan-sulfate epimerase
EC
5.1.3.19
UniProt
Q9UL01
Ligands
NAG, MAN, BMA, MN
Pockets
10 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADermatan-sulfate epimerase (EC 5.1.3.19)protein74337% helix, 20% strandQ9UL01

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 6 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar · 2 copies · chains A
  • BMA · beta-D-mannopyranose · sugar
  • MN · Manganese (II) ion · metal · chains A
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11160.550.8216empty
21400.540.8123empty
31700.510.7818empty
42000.480.7530empty
5840.480.8217empty

Modifications

Observed in the structure: 4 glycan (N-glycosylation).

Compared structures

  • 6HZN · Crystal structure of human dermatan sulfate epimerase 1 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UL01 · AlphaFold monomer V2.0 prediction for dermatan-sulfate epimerase (Q9UL01) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.